Abstract. Previously we found intragranular colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axon terminals of the rat neural lobe. To investigate the function of endothelin-1 in the rat neural lobe, immunoreactive endothelin-1 in plasma and the neural lobe was measured by enzyme immunoassay in rats subjected to hemorrhage and in other rats who were deprived of water for 2 days to induce dehydration. Changes in plasma arginine vasopressin were determined by radioimmunoassay.
ENDOTHELINS
(ET) are a family of homologous peptides, endothelin-1, -2 and -3 (ET-1, -2, -3), with varied biological actions [1: see 2 for review]. ET mRNA [3] [4] [5] [6] , and binding sites or receptors for ET [3, [6] [7] [8] have been found to be distributed widely in mammals, including in the brain. Furthermore, the similarity of localization of both mRNA and receptors for ET suggests that ET may act as a local factor [3, 5, 6] .
Yoshizawa et al. [9] demonstrated immunoreactive (ir-)ET in the hypothalamo-hypophysial neurosecretory system in the pig and rat, as well as ET-1 mRNA in the neurons of the porcine paraventricular nucleus (PVN) by in situ hybridization.
We recently reported that ir-ET-1 was colocalized with ir-vasopressin (VP) or ir-oxytocin (OT) in their respective neurosecretory granules (NSG) in the axon terminals of the rat neural lobe [10] , but the biological significance of the colocalization of ET-1 and neurohypophysial hormones is not yet known.
In the present study, we examined whether or not ir-ET-1 in plasma and the neural lobe in rats is altered in response to acute hemorrhage-induced hypovolemia or to chronic osmotic and hypovolemic stress induced by water deprivation.
In addition, possible changes in the number of NSG and in immunocytochemical reactivity for ET-1 were studied in tissues of the neural lobe of rats exposed to stress. Ir-ET-1 contents were determined by sandwich EIA [14] . The lowest detectable concentration was 0.2 pg/well.
Materials and Methods

Animals
The EIA for ET-1 completely reacted with ET-2, but not with ET-3 (cross-reactivity, <0.2%) [15] .
Extraction and determination of plasma VP Plasma VP was determined with commercially available RIA kits (Mitsubishi Yuka, Tokyo, Japan) after extraction. Briefly, an aliquot of stored plasma (1 ml) was acidified by adding 1 ml of 0.1 N HCl and applied on a Sep-pak C18 cartridge (Waters Associates, Inc. Milford, MA, USA), which was pretreated with 10 ml of methanol and washed twice with 10 ml of de-ionized water. After washing the column with 10 ml of 4% acetic acid, the adsorbed peptide was eluted with 1.5 ml of methanol. The eluates were evaporated, reconstituted, and subjected to RIA. Cross-reactivity of the antiserum with OT was less than 0.01%. The lowest detectable concentration was 0.06 pg/tube.
Immunocytochemistry
Fixation and immunocytochemistry were performed by the previously described methods [10] , with the exception of the rats subjected to 2 days of dehydration which were killed by cardiac perfusion under Nembutal anesthesia with 75 ml 0.9% saline and subsequently with 400 ml 1.5% formaldehyde-1.5% glutaraldehyde fixative that contained 0.2% picric acid and was buffered by 0.1 M sodium cacodylate, pH 7.2. Single immunogold labeling for ET-1 and double immunogold labeling for ET-1 and VP were performed with colloidal gold-labeled goat anti-rabbit immunoglobulin G (1:20; Amersham International plc.). Anti-ET-1 antiserum raised in rabbits was purchased from Immunobiological Laboratory (Fujioka-shi, Japan). The cross-reactivity of the antiserum with ET-2, ET-3, and VP was 1%, 0.4%, and less than 0.4%, respectively. The cross-reactivity of the anti-VP antiserum raised against [Lys8]VP in rabbits (Immunotech, Marseille, France) was 100% with [Arg8]VP and 0.01% with OT.
To test the specificity of immunoreactions, the following preabsorption tests were carried out, as described previously [10] . Preabsorption of each antiserum with the corresponding antigen completely abolished immunoreaction, but that of ET-1 antiserum with ET-2 resulted in only a slight decrease in immunolabeling, compared with that obtained with the untreated anti-ET-1 antiserum. (Table  1) .
There were no significant differences between the hemorrhage and control groups in the number of NSG in the VP axon terminals, nor in immunolabeling for ET-1 on the NSG (Table 1 ; Fig. la, b) . Moreover, there was no evidence of an increase in the number of gold particles over the cytosol in the hemorrhaged rats (Fig. 1b) .
Dehydration experiment
Dehydration for 2 days decreased body weight (35-45 g; median, 42 g) and significantly increased (P<0.01) serum osmolarity and hematocrit.
Plasma it-VP was noticeably increased, while plasma ir-ET-1 remained unchanged.
Ir-ET-1 in the neural lobe was significantly decreased in the dehydrated rats (Table 2 ). In the dehydrated rats, the VP axon terminals contained significantly fewer granules than those in the control rats. Furthermore, the immunoreactivity for ET-1 of the NSG was significantly decreased following dehydration, judging from the number of immunogold particles (Table 2 ; Fig. 2a,  b) .
Discussion
Immunoreactivity for ET-1 and VP was colocalized in the same granules in the axon terminals of the rat neural lobe [101. However, ET-1 might not be cosecreted with VP into the circulation because plasma ir-ET-1 did not increase even though plasma ir-VP was greatly increased after hemorrhage and also after dehydration in the present study. These results suggest that ET-1 in the neural lobe may not function as a circulating hormone.
The abrupt increase in plasma VP immediately after hemorrhage, with no decrease in NSG in the axon terminals, suggests that the magnocellular neurons responded quickly to the acute hypovolemic stimulus by accelerating the axonal flow of NSG and by releasing VP into the systemic circulation. While some believe that ET-1 may also be transported to the neural lobe and released into the circulation together with VP, the above results showed that while the plasma ir-ET-1 concentration remained unchanged, the ir-ET-1 contents in the neural lobe was nearly three-fold higher than the control with no increase in ET-1 immunolabeling in the axon terminals. All these results suggest that ET-1 released from the axon terminals may not be released into the circulation but instead act [7] , and ET-1 potentiated depolarization-induced VP release from nerve terminals in vitro [16] .
It has been reported that water deprivation resulted in a significant increase in VP mRNA in both the PVN and supraoptic nucleus (SON) [17] , as well as a time-dependent decrease in NSG and VP in the neural lobe [18] in the rat. In agreement with these observations, we found a high plasma UEMURA et al. VP concentration and a decreased amount of NSG in the axon terminals following dehydration, suggesting that the synthesis and release of VP had been stimulated, the latter overcoming the former. A significant decrease in ir-ET-1 in the neural lobe following dehydration coincided with the decrease in the NSG and their immunolabeling.
No increase, but a decrease, in ir-ET-1 in the neural lobe suggests either a different mode of action or a degree of involvement of ET-1 under chronic osmotic stress compared with acute hypovolemic stress. The decrease in ir-ET-1 in the NSG suggests that the magnocellular neurons synthesize VP more actively than ET-1 in rats exposed to chronic osmotic stress. Further study, however, is needed to clarify the changes in the rate of ET-1 synthesis during the earlier phase of dehydration.
It is likely that ET-1 affects not only the neurosecretory axon terminals but also the magnocellular perikarya in the PVN and SON to accelerate the release of VP, since ET-1 has also been shown to stimulate the release of VP from the perifused rat hypothalamus [19] , and intracerebroventricularly administered ET-1 increased plasma VP in conscious rabbits [20] and rats [21, 22] . ET-1 may stimulate the release of VP by acting indirectly via stimulation of the catecholaminergic or renin-angiotensinergic system, as was suggested by Yamamoto et al. [21] , or via activation of neurons of the subfornical organ [23] . It is noteworthy that ET can interact with VP also at the level of the kidney: both peptides increase [Na]+i in the glomerular mesangial cells in the rat [24] , whereas ET-1 inhibits VP-dependent cyclic adenosine monophosphate accumulation [25] and VP-stimulated osmotic water permeability [26] in rat collecting ducts.
The results of the present study suggest that ET-1 may be locally involved in the regulation of VP release within the neural lobe following exposure to hypovolemic and/or osmotic stress in rats. Details of the regulatory mechanism, however, remain to be studied.
